Furthermore, the lipid localisation, hormone-mediated signalling pathway, lipid transport, regulation of fatty acid oxidation, response to progesterone, and regulation of transcription are some of the prominent biological processes that may demonstrate the involvement of FATP1 in the progression of various metabolic diseases, including breast cancer. This evidence concerns the gene SLC27A1 and metabolic disease.